Search

Search bills, members, committees and pages...

TRIPP ADAMS

2 federal lobbying filings, 2026.

TRIPP ADAMS is a registered lobbyist named on 2 federal lobbying filings, 2026.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

1 they have filed under, by filings.

RegistrantFilingsReported
BRIDGEBIO PHARMA, INC.2

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$920K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
PHAPharmacy2

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1262Mikaela Naylon Give Kids a Chance Act1
H.R. 1532Scientific EXPERT Act of 20251
H.R. 7148Consolidated Appropriations Act, 20261
S. 822Scientific EXPERT Act of 20251

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
BRIDGEBIO PHARMA, INC.BRIDGEBIO PHARMA, INC.2026 second_quarter$500KJul 20, 2026
BRIDGEBIO PHARMA, INC.BRIDGEBIO PHARMA, INC.2026 first_quarter$420KApr 20, 2026